E. Paliczka

[Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi].

E. Gubała, B. Jarzab, M. Jarzab, 2006, Endokrynologia Polska.

[Relapse of differentiated thyroid carcinoma in low-risk patients].

E. Gubała, J. Krajewska, A. Czarniecka, 2006, Endokrynologia Polska.

NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas

M. Mikuła, B. Czarnocka, K. Bardadin, 2007, British Journal of Cancer.

[Evaluation of the therapeutic benefits in relation to the extent of surgery in patients with differentiated thyroid carcinoma].

S. Półtorak, J. Krajewska, A. Czarniecka, 2006, Endokrynologia Polska.

[Hypoparathyroidism after surgery on thyroid cancer: is there a delayed chance for recovery after a prolonged period of substitutive therapy?].

A. Czarniecka, A. Kukulska, B. Jurecka-Lubieniecka, 2006, Endokrynologia Polska.